| 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis L Fraenkel, JM Bathon, BR England, EW St. Clair, T Arayssi, K Carandang, ... Arthritis & Rheumatology 73 (7), 1108-1123, 2021 | 1286 | 2021 |
| Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events JR Brahmer, H Abu-Sbeih, PA Ascierto, J Brufsky, LC Cappelli, ... Journal for immunotherapy of cancer 9 (6), 2021 | 558 | 2021 |
| Rheumatic and musculoskeletal immune‐related adverse events due to immune checkpoint inhibitors: a systematic review of the literature LC Cappelli, AK Gutierrez, CO Bingham III, AA Shah Arthritis care & research 69 (11), 1751-1763, 2017 | 399 | 2017 |
| Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab LC Cappelli, AK Gutierrez, AN Baer, J Albayda, RL Manno, U Haque, ... Annals of the rheumatic diseases 76 (1), 43-50, 2017 | 393 | 2017 |
| Rheumatic immune-related adverse events from cancer immunotherapy LH Calabrese, C Calabrese, LC Cappelli Nature Reviews Rheumatology 14 (10), 569-579, 2018 | 212 | 2018 |
| Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation TJ Braaten, JR Brahmer, PM Forde, D Le, EJ Lipson, J Naidoo, ... Annals of the rheumatic diseases 79 (3), 332-338, 2020 | 185 | 2020 |
| Sicca syndrome associated with immune checkpoint inhibitor therapy BM Warner, AN Baer, EJ Lipson, C Allen, C Hinrichs, A Rajan, E Pelayo, ... The oncologist 24 (9), 1259-1269, 2019 | 159 | 2019 |
| Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen LC Cappelli, JR Brahmer, PM Forde, DT Le, EJ Lipson, J Naidoo, L Zheng, ... Seminars in arthritis and rheumatism 48 (3), 553-557, 2018 | 149 | 2018 |
| The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis K Suresh, J Naidoo, Q Zhong, Y Xiong, J Mammen, MV De Flores, ... The Journal of clinical investigation 129 (10), 4305-4315, 2019 | 142 | 2019 |
| Immune-related adverse effects of cancer immunotherapy—implications for rheumatology LC Cappelli, AA Shah, CO Bingham Rheumatic Disease Clinics 43 (1), 65-78, 2017 | 136 | 2017 |
| Postapproval comparative safety study of tofacitinib and biological Disease‐Modifying Antirheumatic drugs: 5‐Year results from a United States–based rheumatoid arthritis Registry JM Kremer, CO Bingham III, LC Cappelli, JD Greenberg, AM Madsen, ... ACR Open Rheumatology 3 (3), 173-184, 2021 | 116 | 2021 |
| 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases AR Bass, E Chakravarty, EA Akl, CO Bingham, L Calabrese, LC Cappelli, ... Arthritis care & research 75 (3), 449-464, 2023 | 112 | 2023 |
| Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research DB Johnson, KL Reynolds, RJ Sullivan, JM Balko, JR Patrinely, ... The Lancet Oncology 21 (8), e398-e404, 2020 | 100 | 2020 |
| Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis LC Cappelli, MT Dorak, MP Bettinotti, CO Bingham III, AA Shah Rheumatology 58 (3), 476-480, 2019 | 97 | 2019 |
| A multidisciplinary toxicity team for cancer immunotherapy–related adverse events J Naidoo, J Zhang, EJ Lipson, PM Forde, K Suresh, KF Moseley, S Mehta, ... Journal of the National Comprehensive Cancer Network 17 (6), 712-720, 2019 | 95 | 2019 |
| Inflammatory arthritis: a newly recognized adverse event of immune checkpoint blockade J Naidoo, LC Cappelli, PM Forde, KA Marrone, EJ Lipson, HJ Hammers, ... The oncologist 22 (6), 627-630, 2017 | 86 | 2017 |
| Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature C Calabrese, LC Cappelli, M Kostine, E Kirchner, T Braaten, L Calabrese RMD open 5 (1), e000906, 2019 | 77 | 2019 |
| Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series KF Moseley, J Naidoo, CO Bingham, MA Carducci, PM Forde, GT Gibney, ... Journal for immunotherapy of cancer 6, 1-9, 2018 | 76 | 2018 |
| Checkpoint inhibitor–associated arthritis: A systematic review of case reports and case series N Ghosh, MD Tiongson, C Stewart, KK Chan, B Jivanelli, L Cappelli, ... JCR: Journal of Clinical Rheumatology 27 (8), e317-e322, 2021 | 65 | 2021 |
| Gastrointestinal and hepatic disease in rheumatoid arthritis E Craig, LC Cappelli Rheumatic Disease Clinics 44 (1), 89-111, 2018 | 64 | 2018 |